Loading
Yanuki
SUBCATEGORY FEED
FDA Re-approves Leucovorin as Potential Autism Treatment Amidst Controversy | Vinay Prasad Appointed as Director of FDA Center for Biologics Evaluation and Research | FDA Re-approves Leucovorin as Potential Autism Treatment Amidst Controversy | Vinay Prasad Appointed as Director of FDA Center for Biologics Evaluation and Research

Policy / FDA

FDA Re-approves Leucovorin as Potential Autism Treatment Amidst Controversy

The FDA has re-approved GSK’s Wellcovorin, a branded version of leucovorin, as a potential treatment for autism symptoms. This decision follows a push from the Trump administration, with Health Secretary Robert F. Kennedy Jr. supporting the...

FDA Re-approves Leucovorin as Potential Autism Treatment Amidst Controversy Image via The Washington Post
The drug Trump plans to promote for autism shows real (and fragile) hope
Immigration Environmental Policy Government Regulation Clean Energy Digital Assets FDA Social Media Artificial Intelligence Child Care